Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome
NEJM Evidence · 22.08.2023 · 2 (9)
DOI: 10.1056/evidoa2300012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 22.08.2023. Verfasst von Philip E Mosley und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Brain Networks Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. Hauptthemen laut MEDLINE: Tourette Syndrome, Tics, Cannabidiol. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Brain Networks Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
- Wesley Medical Research Institute, Wesley Hospital, Auchenflower, QLD, Australia.
- Queensland Brain Institute, University of Queensland, St. Lucia, QLD, Australia.
- Australian eHealth Research Centre, CSIRO Health and Biosecurity, Herston, QLD, Australia.
- Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
- The Lambert Initiative for Cannabinoid Therapeutics, University of Sydney, Camperdown, NSW, Australia.
Zitieren
APA
Mosley, P. E., Webb, L., Suraev, A., Hingston, L., Turnbull, T., Foster, K., Ballard, E., Gomes, L., Mohan, A., Sachdev, P. S., Kevin, R., Gordon, R., Benson, M., & McGregor, I. S. (2023). Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome. NEJM Evidence, 2(9). https://doi.org/10.1056/evidoa2300012
Vancouver
Mosley PE, Webb L, Suraev A, Hingston L, Turnbull T, Foster K, et al. Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome. NEJM Evidence. 2023;2(9). doi:10.1056/evidoa2300012
BibTeX
@article{Mosley2023,
author = {Mosley, Philip E and Webb, Lachlan and Suraev, Anastasia and Hingston, Leah and Turnbull, Tracy and Foster, Kelley and Ballard, Emma and Gomes, Lauren and Mohan, Adith and Sachdev, Perminder S and Kevin, Richard and Gordon, Rebecca and Benson, Melissa and McGregor, Iain S},
title = {Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome},
journal = {NEJM Evidence},
year = {2023},
volume = {2},
number = {9},
doi = {10.1056/evidoa2300012}
}
EUVIMED